Patient Group Directions

Applied filters

Patient Group Directions

Care Setting (14)
- Emergency medicine and urgent care (5)
- Occupational Health (6)
- Palliative and End of Life Care (1)
- Primary Care (2)
Events (1)
- Past Events (1)
Guidance (150)
- Administering (10)
- Dosing (2)
- Medication Safety (1)
- Patient Group Directions (150)
- Policy, Commissioning and Managerial (8)
- Safety in Pregnancy (5)
- Service advice and planning (3)
- Supply (11)
- Unlicensed medicines (2)
Medicine (87)
- Aciclovir (2)
- Amoxicillin (1)
- Aspirin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- Ceftriaxone (1)
- Clarithromycin (5)
- Clotrimazole (2)
- Co-amoxiclav (1)
- Copper (1)
- Cytisinicline (1)
- Diamorphine (1)
- Diazepam (2)
- Doxycycline (4)
- Emtricitabine + Tenofovir alafenamide (1)
- Emtricitabine + Tenofovir disoproxil (1)
- Erythromycin (5)
- Estradiol + Dienogest (1)
- Estradiol + Nomegestrol (1)
- Ethinylestradiol + Desogestrel (1)
- Ethinylestradiol + Drospirenone (1)
- Ethinylestradiol + Etonogestrel (1)
- Ethinylestradiol + Gestodene (1)
- Ethinylestradiol + Levonorgestrel (1)
- Ethinylestradiol + Norelgestromin (1)
- Ethinylestradiol + Norethisterone (1)
- Ethinylestradiol + Norgestimate (1)
- Etonogestrel (2)
- Flucloxacillin (2)
- Fluconazole (1)
- Flumazenil (1)
- Fluticasone (1)
- Folic acid (1)
- Fusidic acid (1)
- Gadobutrol (1)
- Gadopiclenol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Gadoxetic acid (1)
- Hydrogen peroxide (1)
- Hyoscine butylbromide (1)
- Imiquimod (1)
- Influenza vaccine (3)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Ketamine (1)
- Levonorgestrel (2)
- Lidocaine (5)
- Lidocaine + Prilocaine (1)
- Malathion (1)
- Medroxyprogesterone (2)
- Meglumine gadobenate (1)
- Metronidazole (2)
- Midazolam (2)
- Mifepristone (1)
- Misoprostol (1)
- Mometasone (1)
- Morphine (1)
- Nitrofurantoin (1)
- Permethrin (1)
- Phenoxymethylpenicillin (2)
- Podophyllotoxin (1)
- Prilocaine (1)
- Progesterone (1)
- Raltegravir (1)
- Sodium chloride (1)
- Tenofovir disoproxil + Emtricitabine (1)
- Terbutaline (1)
- Tramadol (1)
- Tranexamic acid (1)
- Trimethoprim (1)
- Ulipristal (1)
- Valaciclovir (1)
- Varenicline (1)
Publications (93)
- Explainer videos (4)
- Research and audits (3)
- Templates (86)
Specialty (78)
- Infection and infectious diseases (30)
- Neurological disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Radiology (13)
- Renal and urologic disorders (2)
- Reproductive health (14)
- Respiratory disorders (13)
- Sexual health (14)
- Skin disorders (14)
- Smoking cessation (2)
- Vaccinating (3)
Training and Development (6)

PGD use in services provided by multiple organisations

8 April 2024Principles to be considered are outlined for Patient Group Directions used in the provision of medicines/vaccines in services provided by multiple organisations

NHS prescription charges for PGDs or HMR 2012 exemptions

16 September 2024This article summarises the position regarding the levying of prescription charges for medicines supplied under a PGD or an exemption to the HMR 2012.

Delegating PGD authorisation by a Local Authority

8 April 2024It is not permitted for a Local Authority to delegate the authorisation of Patient Group Directions using a Section 75 partnership agreement.

UK Health Security Agency (UKHSA) PGD Templates

8 April 2024Patient Group Direction templates by UKHSA are developed for a range of clinical scenarios. A summary of the processes to use and further links are provided.

Medicines Shortages and Patient Group Directions

24 July 2024This article outlines how PGDs can be managed to allow for their continued use in cases of medicines shortages.

Inclusion of dose ranges in a single Patient Group Direction

10 November 2025The below summarises the considerations required if a single PGD is to include a range of doses.

Off-label or unlicensed product use under HMR 2012 exemptions

8 April 2024A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012

Managing PGDs following organisational change

30 April 2025Advice on the management of PGDs when organisations merge, cease to exist or services are transferred to a new provider to ensure safe care and good governance

Auditing Patient Group Directions

2 June 2025SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.

Gadoteridol contrast agent

4 September 2025SPS PGD template for administering gadoteridol intravenously for imaging investigations and procedures by registered Radiographers.